Lower Expectations for Theravance - Motley Fool
Published by Google Inc. December 31st, 2007 in Google FDA News, Regulatory Affairs eFluxMedia | Lower Expectations for Theravance Motley Fool - Theravance announced last week that the Food and Drug Administration might hold an advisory panel hearing for its lead drug, an antibiotic named Telavancin. ... FDA Approves Fresenius’ Voluven for Surgical Blood Loss |
Lower Expectations for Theravance - Motley Fool
Published by Google Inc. December 31st, 2007 in Google FDA News, Regulatory Affairs
Lower Expectations for Theravance
Motley Fool -
Theravance announced last week that the Food and Drug Administration might hold an advisory panel hearing for its lead drug, an antibiotic named Telavancin. …